Top Updates Back
Astellas Pharma s.r.l.
製品の販売
疾患領域の治療法提供
Rx+事業創成
アクセス向上
サステナビリティ活動
研究開発
パイプライン開発
岡村直樹
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Astellas Pharma Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group Parent
Avara Norman Pharmaceutical Services, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Nippon Medical & Pharmaceutical Co., Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Takeda Pharmaceutical Company, Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Takeda Teba Pharma Co., Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Takeda Teba Pharmaceutical Co., Ltd.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

8 entries
DateDescription
1894 1894年に設立された藤沢薬品工業
1923 1923年に設立された山之内製薬
1940 1940年に山之内薬品商会を創業し、社名を山之内製薬株式会社に改称
1942 1942年本社を東京へ移転
2005-04 2005年4月に発足しました。山之内製薬と藤沢薬品工業の合併により、患者さんを中心に考えるグローバル戦略が形づくられました。
2005-04 Astellas was established in April 2005 through the merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical.
2025-04 2025年4月、創立20周年を迎えました。
2025-04 In April 2025, Astellas celebrated our 20th Anniversary as a company.
+ Loaded when opened
✅
2026-09-21 18:04 (Model: ggml-org/gpt-oss-20b )
↑